SERUM ISOFORM [-2]PROPSA DERIVATES (%P2PSA AND PHI) SIGNIFICANTLY IMPROVES THE PREDICTION OF PROSTATE CANCER AT INITIAL BIOPSY IN A TPSA RANGE 2-10 NG/ML. A MULTICENTRIC EUROPEAN STUDY

Haese, A; Lazzeri, M; de la Taille, A; Palou, J; Mcnicholas, T; Scattoni, V; Lughezzani, G; Larcher, A; Lista, G; Cestari, A; Renter, A; Bosset, Po; Le Corvoisier, P; Fowler, L; Roux, Jwt; Breda, A; de la Torre, P; Bini, V; Buffi, N; Guazzoni, G